216 related articles for article (PubMed ID: 29378945)
1. Adaptation of commensal proliferating
Matamouros S; Hayden HS; Hager KR; Brittnacher MJ; Lachance K; Weiss EJ; Pope CE; Imhaus AF; McNally CP; Borenstein E; Hoffman LR; Miller SI
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1605-1610. PubMed ID: 29378945
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis.
Manor O; Levy R; Pope CE; Hayden HS; Brittnacher MJ; Carr R; Radey MC; Hager KR; Heltshe SL; Ramsey BW; Miller SI; Hoffman LR; Borenstein E
Sci Rep; 2016 Mar; 6():22493. PubMed ID: 26940651
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Gut Microbiota Is Associated with Diarrheagenic
Gallardo P; Izquierdo M; Vidal RM; Chamorro-Veloso N; Rosselló-Móra R; O'Ryan M; Farfán MJ
Front Cell Infect Microbiol; 2017; 7():424. PubMed ID: 29075617
[No Abstract] [Full Text] [Related]
4. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis.
Hoffman LR; Pope CE; Hayden HS; Heltshe S; Levy R; McNamara S; Jacobs MA; Rohmer L; Radey M; Ramsey BW; Brittnacher MJ; Borenstein E; Miller SI
Clin Infect Dis; 2014 Feb; 58(3):396-9. PubMed ID: 24178246
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients - an unrecognized CF pathogen?
Barillova P; Tchesnokova V; Dübbers A; Küster P; Peters G; Dobrindt U; Sokurenko EV; Kahl BC
Int J Med Microbiol; 2014 May; 304(3-4):415-21. PubMed ID: 24630795
[TBL] [Abstract][Full Text] [Related]
7. Virulence potential for extraintestinal infections among commensal Escherichia coli isolated from healthy humans--the Trojan horse within our gut.
Starčič Erjavec M; Žgur-Bertok D
FEMS Microbiol Lett; 2015 Mar; 362(5):. PubMed ID: 25657191
[TBL] [Abstract][Full Text] [Related]
8. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure.
Hayden HS; Eng A; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Martin BD; Leung DH; Heltshe SL; Borenstein E; Miller SI; Hoffman LR
Nat Med; 2020 Feb; 26(2):215-221. PubMed ID: 31959989
[TBL] [Abstract][Full Text] [Related]
9. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
Flass T; Tong S; Frank DN; Wagner BD; Robertson CE; Kotter CV; Sokol RJ; Zemanick E; Accurso F; Hoffenberg EJ; Narkewicz MR
PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710
[TBL] [Abstract][Full Text] [Related]
10. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
11. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848
[TBL] [Abstract][Full Text] [Related]
12. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
[TBL] [Abstract][Full Text] [Related]
13. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
14. CFTR dysregulation drives active selection of the gut microbiome.
Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM
PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings.
Duytschaever G; Huys G; Boulanger L; De Boeck K; Vandamme P
J Cyst Fibros; 2013 Dec; 12(6):780-3. PubMed ID: 23867070
[TBL] [Abstract][Full Text] [Related]
16. Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.
de Freitas MB; Moreira EAM; Tomio C; Moreno YMF; Daltoe FP; Barbosa E; Ludwig Neto N; Buccigrossi V; Guarino A
PLoS One; 2018; 13(6):e0198457. PubMed ID: 29933382
[TBL] [Abstract][Full Text] [Related]
17. The cystic fibrosis gut as a potential source of multidrug resistant pathogens.
Taylor SL; Leong LEX; Sims SK; Keating RL; Papanicolas LE; Richard A; Mobegi FM; Wesselingh S; Burr LD; Rogers GB
J Cyst Fibros; 2021 May; 20(3):413-420. PubMed ID: 33250435
[TBL] [Abstract][Full Text] [Related]
18. Human Escherichia coli isolates from hemocultures: Septicemia linked to urogenital tract infections is caused by isolates harboring more virulence genes than bacteraemia linked to other conditions.
Micenková L; Beňová A; Frankovičová L; Bosák J; Vrba M; Ševčíková A; Kmeťová M; Šmajs D
Int J Med Microbiol; 2017 Apr; 307(3):182-189. PubMed ID: 28268063
[TBL] [Abstract][Full Text] [Related]
19. Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.
Antosca KM; Chernikova DA; Price CE; Ruoff KL; Li K; Guill MF; Sontag NR; Morrison HG; Hao S; Drumm ML; MacKenzie TA; Dorman DB; Feenan LM; Williams MA; Dessaint J; Yuan IH; Aldrich BJ; Moulton LA; Ting L; Martinez-Del Campo A; Stewart EJ; Karagas MR; O'Toole GA; Madan JC
J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31209076
[TBL] [Abstract][Full Text] [Related]
20. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
